Wolfgang Gross

Dr. Wolfgang Gross

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Cancer Letters
Verified
Journal Article
Open access
CGChristina Georgikou
Christina Georgikou
LYLibo Yin
Libo Yin
JGJury Gladkich
Jury Gladkich
XXXi Xiao
Xi Xiao
CSCarsten Sticht
Carsten Sticht
Ingrid HerrIngrid Herr
Ingrid Herr
The therapy resistance of pancreatic cancer is associated with the loss of gap junction intercellular communication and connexin 43 expression. The broccoli isothiocyanate sulforaphane restored these features and therapy sensitivity. We investigated whether microRNA signaling is involved. Established cell lines and a patient tissue array (n = 96) were evaluated by miRNA and gene array, bioinformatics, expression studies, in situ hybridization and immunohistochemistry. Sulforaphane inhibited the expression of our top candidate miR30a-3p. Upon transfection of miR30a-3p inhibitors, the gemcitabine bystander effect, Cx43 expression and intercellular communication increased, whereas miR30a-3p mimics inhibited the luciferase activity of a Cx43 3'-UTR construct. miR30a-3p-overexpressing tumor xenografts had a decreased tumor volume and increased gemcitabine sensitivity. In patient tissues, a higher expression of miR30a-3p and a lower expression of Cx43 correlated with malignancy. These findings provide new knowledge and suggest sulforaphane as cotreatment for pancreatic cancer.

1 July 2018 in Cancer Letters
Verified
Journal Article
Closed access
YYYefeng Yin
Yefeng Yin
LLLi Liu
Li Liu
ZZZhefu Zhao
Zhefu Zhao
LYLibo Yin
Libo Yin
NBNathalie Bauer
Nathalie Bauer
Ingrid HerrIngrid Herr
Ingrid Herr

1 June 2019 in Cancer Letters
Verified
Journal Article
Closed access
LYLibo Yin
Libo Yin
XXXi Xiao
Xi Xiao
CGChristina Georgikou
Christina Georgikou
YYYefeng Yin
Yefeng Yin
LLLi Liu
Li Liu
Ingrid HerrIngrid Herr
Ingrid Herr


15 May 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
CGChristina Georgikou
Christina Georgikou
LBLaura Buglioni
Laura Buglioni
MBMaximilian Bremerich
Maximilian Bremerich
NRNico Roubicek
Nico Roubicek
LYLibo Yin
Libo Yin
Ingrid HerrIngrid Herr
Ingrid Herr
The naturally occurring isothiocyanate sulforaphane, found in Brassicaceae vegetables, is promising in cancer treatment, e.g., by the normalization of enhanced levels of NF-κB-signaling in tumor stem cells. We chemically synthesized seven sulforaphane analogues by substitution of the sulfinyl group (S(O)) to either sulfimidoyl (S(NR)) or sulfonimidoyl (S (O) (NR)) groups, and characterized them in the cell lines of pancreatic cancer and several other tumor entities, including the NCI-60 cell panel. MTT and colony forming assays, flow cytometry, immunohistochemistry, microRNA arrays, bioinformatics, tumor xenotransplantation, and Kaplan Meier survival curves were performed. Compared to sulforaphane, the analogue SF102 was most efficient in inhibition of viability, colony formation, tumor growth, and the induction of apoptosis, followed by SF134. Side effects were not observed, as concluded from the body weight and liver histology of chick embryos and survival of C. elegans nematodes. Among 6659 differentially regulated microRNAs, miR29b-1-5p, and miR-27b-5p were downregulated by sulforaphane compared to controls, but upregulated by SF102 and SF134 compared to sulforaphane, suggesting differential signaling. Each substance was involved in the regulation of several NF-κB-related target genes. In conclusion, sulforaphane analogues are promising for the development of highly active new drugs in cancer treatment.

21 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
EKEva-Maria Kamionka
Eva-Maria Kamionka
BQBaifeng Qian
Baifeng Qian
WGWolfgang Gross
Wolfgang Gross
FBFrank Bergmann
Frank Bergmann
Thilo HackertThilo Hackert
Thilo Hackert
Eduard RyschichEduard Ryschich
Eduard Ryschich
The dominant intrastromal T-cell infiltration in pancreatic cancer is mainly caused by the contact guidance through the excessive desmoplastic reaction and could represent one of the obstacles to an effective immune response in this tumor type. This study analyzed the collagen organization in normal and malignant pancreatic tissues as well as its influence on T-cell distribution in pancreatic cancer. Human pancreatic tissue was analyzed using immunofluorescence staining and multiphoton and SHG microscopy supported by multistep image processing. The influence of collagen alignment on activated T-cells was studied using 3D matrices and time-lapse microscopy. It was found that the stroma of malignant and normal pancreatic tissues was characterized by complex individual organization. T-cells were heterogeneously distributed in pancreatic cancer and there was no relationship between T-cell distribution and collagen organization. There was a difference in the angular orientation of collagen alignment in the peritumoral and tumor-cell-distant stroma regions in the pancreatic ductal adenocarcinoma tissue, but there was no correlation in the T-cell densities between these regions. The grade of collagen alignment did not influence the directionality of T-cell migration in the 3D collagen matrix. It can be concluded that differences in collagen organization do not change the spatial orientation of T-cell migration or influence stromal T-cell distribution in human pancreatic cancer. The results of the present study do not support the rationale of remodeling of stroma collagen organization for improvement of T-cell–tumor cell contact in pancreatic ductal adenocarcinoma.